🇦🇺 UMECLIDINIUM BROMIDE in Australia

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in Australia.

Marketing authorisation

TGA

  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in Australia?

Yes. TGA has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in Australia?

Marketing authorisation holder not available in our data.